Nomura Holdings
MIRM icon

Nomura Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

Nomura Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Sell
3,701
-15,897
-81% -$1.6M ﹤0.01% 1545
2026
Q1 		$1.81M Buy
19,598
+9,722
+98% +$915K ﹤0.01% 962
2025
Q4 		$780K Buy
+9,876
New +$709K ﹤0.01% 1412

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nomura Holdings's MIRM Position: Q2 2026 in Review

Nomura Holdings reduced its Mirum Pharmaceuticals (MIRM) stake by 81% in Q2 2026, selling an estimated $1.6M and leaving 3,701 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Nomura Holdings first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.81M in Q1 2026. 300 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Nomura Holdings held 3,701 shares of Mirum Pharmaceuticals worth $433K as of Q2 2026.
  • Nomura Holdings sold 15,897 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.6M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1545 holding.
  • Nomura Holdings first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Nomura Holdings's Mirum Pharmaceuticals position peaked at $1.81M in Q1 2026.
  • 300 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.